Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion

Oncogene volume 41, pages 1795–1808 (2022)Cite this article

Subjects

Abstract

Trop-2 is a transmembrane signal transducer that is overexpressed in most human cancers, and drives malignant progression. To gain knowledge on the higher-order molecular mechanisms that drive Trop-2 signaling, we applied next-generation sequencing, proteomics, and high-resolution microscopy to models and primary cases of human colorectal cancer (CRC). We had previously shown that Trop-2 induces a Ca2+ signal. We reveal here that Trop-2 binds the cell membrane Na+/K+-ATPase, and that clustering of Trop-2 induces an intracellular Ca2+ rise followed by membrane translocation of PKCα, which in turn phosphorylates the Trop-2 cytoplasmic tail. This feed-forward signaling is promoted by the binding of Trop-2 to the PKCα membrane-anchor CD9. CRISPR-based inactivation of CD9 in CRC cells shows that CD9 is required by Trop-2 for recruiting PKCα and cofilin-1 to the cell membrane. This induces malignant progression through proteolytic cleavage of E-cadherin, remodeling of the β-actin cytoskeleton, and activation of Akt and ERK. The interaction between Trop-2 and CD9 was validated in vivo in murine models of CRC growth and invasion. Overexpression of the components of this Trop-2-driven super-complex significantly worsened disease-free and overall survival of CRC patients, supporting a pivotal relevance in CRC malignant progression. Our findings demonstrate a previously unsuspected layer of cancer growth regulation, which is dormant in normal tissues, and is activated by Trop-2 in cancer cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Trop-2 induces intracellular Ca2+ rise through Na+/K+-ATPase.
Fig. 2: The Trop-2 cytoplasmic tail is required for PKCα recruitment to the cell membrane but not for intracellular Ca2+ rise.
Fig. 3: The Trop-2/PKCα feed-forward signaling.
Fig. 4: Trop-2 modulates cytoskeletal dynamics and interacts with CD9 at the cell membrane.
Fig. 5: CD9 is an obligate mediator of Trop-2 signaling.
Fig. 6: The Trop-2-centered growth control module.
Fig. 7: Expression of the Trop-2-driven super-complex correlates with the clinical outcome of patients with CRC.

Similar content being viewed by others

References

  1. Guerra E, Trerotola M, Aloisi AL, Tripaldi R, Vacca G, La Sorda R, et al. The Trop-2 signalling network in cancer growth. Oncogene. 2013;32:1594–600.

    Article  CAS  PubMed  Google Scholar 

  2. Trerotola M, Cantanelli P, Guerra E, Tripaldi R, Aloisi AL, Bonasera V, et al. Up-regulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene. 2013;32:222–33.

    Article  CAS  PubMed  Google Scholar 

  3. Guerra E, Trerotola M, Tripaldi R, Aloisi AL, Simeone P, Sacchetti A, et al. Trop-2 induces tumor growth through Akt and determines sensitivity to Akt inhibitors. Clin Cancer Res. 2016;22:4197–205.

    Article  CAS  PubMed  Google Scholar 

  4. Trerotola M, Li J, Alberti S, Languino LR. Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis. J Cell Physiol. 2012;227:3670–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Guerra E, Trerotola M, Dell’ Arciprete R, Bonasera V, Palombo B, El-Sewedy T, et al. A bi-cistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res. 2008;68:8113–21.

    Article  CAS  PubMed  Google Scholar 

  6. Trerotola M, Guerra E, Ali Z, Aloisi AL, Ceci M, Simeone P, et al. Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis. Neoplasia. 2021;23:415–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Rios-Doria J, Day KC, Kuefer R, Rashid MG, Chinnaiyan AM, Rubin MA, et al. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem. 2003;278:1372–9.

  8. Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci USA. 2005;102:9182–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Guerra E, Trerotola M, Relli V, Lattanzio R, Tripaldi R, Vacca G, et al. Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer. Neoplasia. 2021;23:898–911.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ripani E, Sacchetti A, Corda D, Alberti S. The human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer. 1998;76:671–6.

    Article  CAS  PubMed  Google Scholar 

  11. Thomas A, Pommier Y. Targeting topoisomerase I in the era of precision medicine. Clin Cancer Res. 2019;25:6581–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bardia A, Mayer IA, Vahdat LT, Tolaney SM, Isakoff SJ, Diamond JR, et al. Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer. N Engl J Med. 2019;380:741–51.

    Article  CAS  PubMed  Google Scholar 

  13. Fornaro M, Dell’Arciprete R, Stella M, Bucci C, Nutini M, Capri MG, et al. Cloning of the gene encoding TROP-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer. 1995;62:610–8.

    Article  CAS  PubMed  Google Scholar 

  14. El Sewedy T, Fornaro M, Alberti S. Cloning of the murine Trop2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of Trop-2. Int J Cancer. 1998;75:324–30.

    Article  CAS  PubMed  Google Scholar 

  15. Alberti S, Miotti S, Stella M, Klein CE, Fornaro M, Ménard S, et al. Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2. Hybridoma. 1992;11:539–5.

    Article  CAS  PubMed  Google Scholar 

  16. Moore EDW, Etter EF, Philipson KD, Carrington WA, Fogarty KE, Lifshitz LM, et al. Coupling of the Na+/Ca2+exchanger, Na+/K+ pump and sarcoplasmic reticulum in smooth muscle. Nature. 1993;365:657–60.

    Article  CAS  PubMed  Google Scholar 

  17. Liang M, Tian J, Liu L, Pierre S, Liu J, Shapiro J, et al. Identification of a Pool of Non-pumping Na/K-ATPase. J Biol Chem. 2007;282:10585–93.

    Article  CAS  PubMed  Google Scholar 

  18. Tian J, Cai T, Yuan Z, Wang H, Liu L, Haas M, et al. Binding of Src to Na+/K+-ATPase forms a functional signaling complex. Mol Biol Cell. 2005;17:317–26.

    Article  PubMed  Google Scholar 

  19. Tian J, Xie ZJ. The Na-K-ATPase and calcium-signaling microdomains. Physiology. 2008;23:205–11.

    Article  CAS  PubMed  Google Scholar 

  20. Matchkov VV, Krivoi II. Specialized functional diversity and interactions of the Na,K-ATPase. Front Physiol. 2016;7:179.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Haas M, Wang H, Tian J, Xie Z. Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem. 2002;277:18694–702.

    Article  CAS  PubMed  Google Scholar 

  22. Shen J-J, Zhan Y-C, Li H-Y, Wang Z. Ouabain impairs cancer metabolism and activates AMPK-Src signaling pathway in human cancer cell lines. Acta Pharmacol Sin. 2020;41:110–8.

    Article  CAS  PubMed  Google Scholar 

  23. Chen D, Song M, Mohamad O, Yu SP. Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells. BMC Cancer. 2014;14:716.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Tian J, Li X, Liang M, Liu L, Xie JX, Ye Q, et al. Changes in sodium pump expression dictate the effects of ouabain on cell growth. J Biol Chem. 2009;284:14921–9.

  25. Ninsontia C, Chanvorachote P. Ouabain mediates integrin switch in human lung cancer cells. Anticancer Res. 2014;34:5495.

    CAS  PubMed  Google Scholar 

  26. Larre I, Lazaro A, Contreras RG, Balda MS, Matter K, Flores-Maldonado C, et al. Ouabain modulates epithelial cell tight junction. Proc Natl Acad Sci. 2010;107:11387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 1988;48:6863–71.

    CAS  PubMed  Google Scholar 

  28. Basu A, Goldenberg DM, Stein R. The epithelial/carcinoma antigen EGP-1, recognized by monoclonal antibody RS7-3G11, is phosphorylated on serine 303. Int J Cancer. 1995;62:472–9.

  29. Wanger TM, Dewitt S, Collins A, Maitland NJ, Poghosyan Z, Knauper V. Differential regulation of TROP2 release by PKC isoforms through vesicles and ADAM17. Cell Signal. 2015;27:1325–35.

  30. Mori Y, Akita K, Ojima K, Iwamoto S, Yamashita T, Morii E, et al. Trophoblast cell surface antigen 2 (Trop-2) phosphorylation by protein kinase C alpha/delta (PKCalpha/delta) enhances cell motility. J Biol Chem. 2019;294:11513–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Farah CA, Sossin WS. The role of C2 domains in PKC signaling. Adv Exp Med Biol. 2012;740:663–83.

    Article  CAS  PubMed  Google Scholar 

  32. Alberti S. A phosphoinositide-binding sequence is shared by PH domain target molecules–a model for the binding of PH domains to proteins. Proteins. 1998;31:1–9.

    Article  CAS  PubMed  Google Scholar 

  33. Alberti S. HIKE, a candidate protein binding site for PH domains, is a major regulatory region of Gbeta proteins. Proteins. 1999;35:360–3.

    Article  CAS  PubMed  Google Scholar 

  34. Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell. 2017;169:381–405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Freeley M, Kelleher D, Long A. Regulation of protein kinase C function by phosphorylation on conserved and non-conserved sites. Cell Signal. 2011;23:753–62.

    Article  CAS  PubMed  Google Scholar 

  36. Tanaka K, Babic I, Nathanson D, Akhavan D, Guo D, Gini B, et al. Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. Cancer Discov. 2011. https://doi.org/10.1158/2159-8290.CD-11-0124.

  37. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol. 2004;14:1296–302.

    Article  CAS  PubMed  Google Scholar 

  38. Trerotola M, Ganguly KK, Fazli L, Fedele C, Lu H, Dutta A, et al. Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts. Oncotarget. 2015.

  39. Trerotola M, Jernigan D, Liu Q, Siddiqui J, Fatatis A, Languino L. Trop-2 promotes prostate cancer metastasis by modulating β1 integrin functions. Cancer Res. 2013;73:3155–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. van Rheenen J, Song X, van Roosmalen W, Cammer M, Chen X, DesMarais V, et al. EGF-induced PIP2 hydrolysis releases and activates cofilin locally in carcinoma cells. J Cell Biol. 2007;179:1247–59.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Spratley SJ, Bastea LI, Doppler H, Mizuno K, Storz P. Protein kinase D regulates cofilin activity through p21-activated kinase 4. J Biol Chem. 2011;286:34254–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Sakuma M, Shirai Y, Yoshino K-I, Kuramasu M, Nakamura T, Yanagita T, et al. Novel PKCα-mediated phosphorylation site(s) on cofilin and their potential role in terminating histamine release. Mol Biol Cell. 2012;23:3707–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Saczko-Brack D, Warchol E, Rogez B, Kross M, Heissler SM, Sellers JR, et al. Self-organization of actin networks by a monomeric myosin. Proc Natl Acad Sci USA. 2016;113:E8387–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Choi CK, Vicente-Manzanares M, Zareno J, Whitmore LA, Mogilner A, Horwitz AR. Actin and α-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner. Nat Cell Biol. 2008;10:1039–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Watanabe T, Hosoya H, Yonemura S. Regulation of myosin II dynamics by phosphorylation and dephosphorylation of its light chain in epithelial cells. Mol Biol Cell. 2007;18:605–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Zanna P, Trerotola M, Vacca G, Bonasera V, Palombo B, Guerra E, et al. Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression. Cancer. 2007;110:452–64.

    Article  CAS  PubMed  Google Scholar 

  47. Ng T, Shima D, Squire A, Bastiaens PIH, Gschmeissner S, Humphries MJ, et al. PKCα regulates β1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J. 1999;18:3909–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Zhang XA, Bontrager AL, Hemler ME. Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J Biol Chem. 2001;276:25005–13.

    Article  CAS  PubMed  Google Scholar 

  49. Jiang X, Teng M, Ji R, Zhang D, Zhang Z, Lv Y, et al. CD9 regulates keratinocyte differentiation and motility by recruiting E-cadherin to the plasma membrane and activating the PI3K/Akt pathway. Biochim Biophys Acta. 2020;1867:118574.

    Article  CAS  Google Scholar 

  50. Cabantous S, Nguyen HB, Pedelacq J-D, Koraïchi F, Chaudhary A, Ganguly K, et al. A new protein-protein interaction sensor based on tripartite split-GFP association. Sci Rep. 2013;3:2854.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Wang H-X, Kolesnikova TV, Denison C, Gygi SP, Hemler ME. The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization. J Cell Sci. 2011;124:2702–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Sveen A, Ågesen TH, Nesbakken A, Rognum TO, Lothe RA, Skotheim RI. Transcriptome instability in colorectal cancer identified by exon microarray analyses: associations with splicing factor expression levels and patient survival. Genome Med. 2011;3:32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Ågesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, Skotheim RI, et al. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut. 2012;61:1560.

    Article  PubMed  Google Scholar 

  54. Ambrogi F, Fornili M, Boracchi P, Trerotola M, Relli V, Simeone P, et al. Trop-2 is a determinant of breast cancer survival. PLoS ONE. 2014;9:e96993.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Stoyanova T, Goldstein AS, Cai H, Drake JM, Huang J, Witte ON. Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via beta-catenin signaling. Genes Dev. 2012;26:2271–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Mochly-Rosen D, Gordon AS. Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J. 1998;12:35–42.

    Article  CAS  PubMed  Google Scholar 

  57. Murayama Y, Shinomura Y, Oritani K, Miyagawa J, Yoshida H, Nishida M, et al. The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells. J Cell Physiol. 2008;216:135–43.

    Article  CAS  PubMed  Google Scholar 

  58. Powner D, Kopp Petra M, Monkley Susan J, Critchley David R, Berditchevski F. Tetraspanin CD9 in cell migration. Biochem Soc Trans. 2011;39:563–7.

    Article  CAS  PubMed  Google Scholar 

  59. Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, et al. Extracellular vesicle and particle biomarkers define multiple human cancers. Cell. 2020;182:1044–61.e18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Krishn SR, Singh A, Bowler N, Duffy AN, Friedman A, Fedele C, et al. Prostate cancer sheds the αvβ3 integrin in vivo through exosomes. Matrix Biol. 2019;77:41–57.

    Article  CAS  PubMed  Google Scholar 

  61. Ciccarelli F, Acciarito A, Alberti S. Large and diverse numbers of human diseases with HIKE mutations. Hum Mol Genet. 2000;9:1001–7.

    Article  CAS  PubMed  Google Scholar 

  62. Antal CE, Hudson AM, Kang E, Zanca C, Wirth C, Stephenson NL, et al. Cancer-associated protein kinase C mutations reveal kinase’s role as tumor suppressor. Cell. 2015;160:489–502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11:783–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Bahmad HF, Cheaito K, Chalhoub RM, Hadadeh O, Monzer A, Ballout F, et al. Sphere-formation assay: three-dimensional in vitro culturing of prostate cancer stem/progenitor sphere-forming cells. Front Oncol. 2018;8:347.

  65. Scott RW, Hooper S, Crighton D, Li A, Konig I, Munro J, et al. LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J Cell Biol. 2010;191:169–85.

  66. Di Baldassarre A, D’Amico MA, Izzicupo P, Gaggi G, Guarnieri S, Mariggiò MA, et al. Cardiomyocytes derived from human cardiopoieticamniotic fluids. Sci Rep. 2018;8:12028.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank G. Vacca, F. Dini, E. Eleuterio, and S. Angelucci for help during the course of this work. We also thank C. Berrie for language editing of the paper.

Funding

Italian Ministry of Health (RicOncol RF-EMR-2006-361866), Italian Ministry of Development—FESR 2016–2018. SSI000651, art. 69 Reg. (CE) n. 1083/2006 and Reg. (CE) n. 1828/2006, Region Abruzzo (POR FESR 2007–2013: Activity 1.1.1 line B) C78C14000100005, Oncoxx Biotech, Italy and Marie Curie Transfer of Knowledge Fellowship—EC VI Framework Program (Contract 014541) to SA. Programma Per Giovani Ricercatori “Rita Levi Montalcini”, Italian Ministry of University and Research (Grant PGR12I7N1Z) to MT. EG is an inventor in patents WO201687651 and WO201784763, and a partner in Mediterranea Theranostic Srl. MT is an inventor in patent WO201784763. SA is an inventor in patents WO201089782, WO201687651, and WO201784763, and is founder and CEO of Oncoxx Biotech Srl and Mediterranea Theranostic Srl. VR was an employee of Oncoxx Biotech Srl. PS is an inventor in a patent application under consideration (EP3546948).

Author information

Author notes

  1. Pasquale Simeone

    Present address: Department of Medicine and Aging Sciences, University “G. D’Annunzio”, Chieti, Italy

  2. Pasquale Simeone

    Present address: Laboratory of Cytomorphology, Center for Advanced Studies and Technology (CAST), University “G. D’Annunzio”, Chieti, Italy

  3. Andrea Sacchetti

    Present address: Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands

  4. Kristina Havas

    Present address: FIRC Institute of Molecular Oncology (IFOM), Milan, Italy

  5. These authors contributed equally: Marco Trerotola, Saverio Alberti.

Authors and Affiliations

  1. Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), University “G. D’Annunzio”, Chieti, Italy

    Emanuela Guerra, Valeria Relli, Martina Ceci, Romina Tripaldi, Pasquale Simeone, Anna Laura Aloisi, Ludovica Pantalone, Rossana La Sorda, Rossano Lattanzio, Andrea Sacchetti, Kristina Havas, Mauro Piantelli, Marco Trerotola & Saverio Alberti

  2. Department of Medical, Oral and Biotechnological Sciences, University “G. D’Annunzio”, Chieti, Italy

    Emanuela Guerra, Nicola Tinari, Mauro Piantelli & Marco Trerotola

  3. Department of Innovative Technologies in Medicine & Dentistry, University “G.D’Annunzio”, Chieti, Italy

    Rossano Lattanzio

  4. Laboratory of Cell Physiology, Center for Advanced Studies and Technology (CAST), University “G. D’Annunzio”, Chieti, Italy

    Simone Guarnieri

  5. Department of Neuroscience, Imaging and Clinical Sciences, University “G. D’Annunzio”, Chieti, Italy

    Simone Guarnieri

  6. Department of Biological and Environmental Sciences and Technologies, University of Salento, Lecce, Italy

    Daniele Vergara

  7. Inserm U-1192, Laboratoire de Protéomique, Réponse Inflammatoire, Spectrométrie de Masse, Université de Lille 1, Cité Scientifique, Villeneuve D’Ascq Cedex, France

    Isabelle Fournier & Michel Salzet

  8. Unit of Medical Genetics, Department of Biomedical Sciences, University of Messina, Messina, Italy

    Saverio Alberti

Authors
  1. Emanuela Guerra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valeria Relli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martina Ceci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Romina Tripaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pasquale Simeone
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anna Laura Aloisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ludovica Pantalone
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rossana La Sorda
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rossano Lattanzio
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Andrea Sacchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Kristina Havas
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Simone Guarnieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Daniele Vergara
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Isabelle Fournier
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Michel Salzet
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Nicola Tinari
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Mauro Piantelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Marco Trerotola
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Saverio Alberti
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MT, VR, RT, AS, KH, PS, EG, MC, and and ALA performed the biochemical and functional assays; RLS, RL, NT, and MP collected the human tumor samples, assembled tissue microarrays, and performed IHC analysis; DV. performed the 2D-PAGE and the NanoLC-MS/MS assays; DV, IF, and MS analyzed the data from NanoLC and MS/MS assays; MT and SA planned the study and wrote the paper.

Corresponding authors

Correspondence to Marco Trerotola or Saverio Alberti.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

All procedures involving animal care were approved by the Interuniversity Animal Research Ethics Committee (CEISA), Chieti-Pescara and Teramo Universities (Prot. 26/2011/CEISA/PROG/16), and were conducted in compliance with consensus international protocols (D.L. No. 116, G.U. Feb. 18,1992; No. 8, G.U. July, 1994; UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia; EEC Council Directive 86/609, Dec. 12,1987; Guide for the Care and Use of Laboratory Animals, US-NRC,1996). Studies on human tumor samples were approved by the Italian Ministry of Health (RicOncol RF-EMR-2006-361866).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guerra, E., Relli, V., Ceci, M. et al. Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion. Oncogene 41, 1795–1808 (2022). https://doi.org/10.1038/s41388-022-02220-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41388-022-02220-1

This article is cited by

Search

Advanced search

Quick links